Literature DB >> 23939156

[Expression of circulating microRNAs in patients with bladder urothelial carcinoma].

Zhi-cao Zhang1, Yi Huang, Xiu-jie Wang, Meng Wang, Lu-lin Ma.   

Abstract

OBJECTIVE: To search for differentially expressed microRNAs in circulation and to explore their potential application as non-invasive biomarkers for bladder urothelial carcinoma.
METHODS: Six bladder urothelial carcinoma patients were recruited into this study, and blood from seven non-tumor patients was included as the controls. Total small RNAs were isolated from the blood. By using high-throughput sequencing technologies, we provided microRNA expression profiles of bladder urothelial carcinoma patients and the control group. The data were analyzed using T test of the SPSS17.0 software to study the expression differences of microRNAs between the two groups.
RESULTS: The work identified some microRNAs with differential expression in circulation between the bladder urothelial carcinoma patients and the non-tumor patients. Five microRNAs (hsa-miR-378g, hsa-miR-942, hsa-miR-106a-5p, hsa-miR-142-3p and hsa-miR-374a) were identified to be upregulated in the patients, and the expressions of many other microRNAs were significantly downregulated.
CONCLUSION: The study reveals that there is a variance of microRNA expression profile in circulation between bladder urothelial and non neoplastic populations,The results need further study by large samples.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23939156

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  8 in total

1.  MicroRNA-576-3p inhibits proliferation in bladder cancer cells by targeting cyclin D1.

Authors:  Zhen Liang; Shiqi Li; Xin Xu; Xianglai Xu; Xiao Wang; Jian Wu; Yi Zhu; Zhenghui Hu; Yiwei Lin; Yeqing Mao; Hong Chen; Jindan Luo; Ben Liu; Xiangyi Zheng; Liping Xie
Journal:  Mol Cells       Date:  2014-12-30       Impact factor: 5.034

2.  MiR-374a promotes the proliferation of osteosarcoma cell proliferation by targeting Axin2.

Authors:  Tan Lu; Chao Zhang; Ming-Xiang Chai; Yong-Bo An; Jin-Ling Jia
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 3.  MicroRNAs as potential biomarkers in cancer: opportunities and challenges.

Authors:  Huiyin Lan; Haiqi Lu; Xian Wang; Hongchuan Jin
Journal:  Biomed Res Int       Date:  2015-03-22       Impact factor: 3.411

Review 4.  Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure.

Authors:  Fan Dong; Tianyuan Xu; Yifan Shen; Shan Zhong; Shanwen Chen; Qiang Ding; Zhoujun Shen
Journal:  Oncotarget       Date:  2017-04-18

5.  Comprehensive Analysis of Aberrantly Expressed ceRNA network in gastric cancer with and without H.pylori infection.

Authors:  Aining Chu; Jingwei Liu; Yuan Yuan; Yuehua Gong
Journal:  J Cancer       Date:  2019-01-29       Impact factor: 4.207

6.  miR-942 promotes proliferation and metastasis of hepatocellular carcinoma cells by inhibiting RRM2B.

Authors:  Qifan Zhang; Bili Zhu; Jianping Qian; Kai Wang; Jie Zhou
Journal:  Onco Targets Ther       Date:  2019-10-11       Impact factor: 4.147

7.  Exploring microRNA target genes and identifying hub genes in bladder cancer based on bioinformatic analysis.

Authors:  Hongjian Wu; Wubing Jiang; Guanghua Ji; Rong Xu; Gaobo Zhou; Hongyuan Yu
Journal:  BMC Urol       Date:  2021-06-10       Impact factor: 2.264

8.  Global population-specific variation in miRNA associated with cancer risk and clinical biomarkers.

Authors:  Renata A Rawlings-Goss; Michael C Campbell; Sarah A Tishkoff
Journal:  BMC Med Genomics       Date:  2014-08-28       Impact factor: 3.063

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.